SYMTUZA 800 MG/150 MG/200 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
SYMTUZA 800 MG/150 MG/200 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Pending
Register Number
1171225001IP
Prescription Type
Uso Hospitalario
Authorization Date
Nov 2, 2021
Dosage Form
COMPRIMIDO
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1171225001IP
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (4)
COBICISTATActive
Quantity: 150 mg
Name: COBICISTAT
DARUNAVIR ETANOLATOActive
Quantity: 800 mg
Name: DARUNAVIR ETANOLATO
EMTRICITABINAActive
Quantity: 200 mg
Name: EMTRICITABINA
TENOFOVIR ALAFENAMIDA FUMARATOActive
Quantity: 10 mg
Name: TENOFOVIR ALAFENAMIDA FUMARATO
ATC CLASSIFICATION (3)
J05A
J05AR
J05AR22